2020
DOI: 10.1590/pboci.2020.126
|View full text |Cite
|
Sign up to set email alerts
|

SARS-CoV-2 and Saliva as a Diagnostic Tool: A Real Possibility

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
6
0
4

Year Published

2021
2021
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 20 publications
1
6
0
4
Order By: Relevance
“…(13) Herein we tested gingival fluid as a specimen for SARS-CoV-2 detection by RT-qPCR, and we found a poor concordance rate (15.38%) among RT-qPCR positive samples from NP swabs. Although our data is in agreement with previous data, our concordance rate among positive results was lower than the those reported by Ku et al (14) and Kam et al (12) . This variation may be due to the study designs that differed regarding the moment of sample collection in relation to NP swab collection, the number of sample collection time points (single or multiple days), and the way (selfor healthcare professional-performed collection) samples were collected.…”
Section: Discussionsupporting
confidence: 85%
See 1 more Smart Citation
“…(13) Herein we tested gingival fluid as a specimen for SARS-CoV-2 detection by RT-qPCR, and we found a poor concordance rate (15.38%) among RT-qPCR positive samples from NP swabs. Although our data is in agreement with previous data, our concordance rate among positive results was lower than the those reported by Ku et al (14) and Kam et al (12) . This variation may be due to the study designs that differed regarding the moment of sample collection in relation to NP swab collection, the number of sample collection time points (single or multiple days), and the way (selfor healthcare professional-performed collection) samples were collected.…”
Section: Discussionsupporting
confidence: 85%
“…As for saliva, it has already been shown to be a possible reliable specimen for SARS-CoV-2 detection and this sample type has been previously used for the detection of other respiratory viruses, including SARS-CoV. (14) The main argument behind the use of saliva as a specimen for SARS-CoV-2 detection, apart from the comfort of the patient during sample collection, was biosafety. Therefore, in order to simulate a self-collecting sampling in our cohort, we did not assist every individual collection, although every subject was advised on how to perform the collection.…”
Section: Discussionmentioning
confidence: 99%
“…The current diagnostic standard involves detection of SARS‐CoV‐2 by reverse‐transcription polymerase chain reaction (RT‐PCR) using nasopharyngeal swabs (NPS). However, NPS are associated with patient's discomfort or complications—such as iatrogenic cerebrospinal fluid leak—as well as an increasing healthcare worker's exposure to SARS‐CoV‐2 1,2 …”
Section: Introductionmentioning
confidence: 99%
“…However, NPS are associated with patient's discomfort or complications-such as iatrogenic cerebrospinal fluid leak-as well as an increasing healthcare worker's exposure to SARS-CoV-2. 1,2 Saliva is an attractive and noninvasive option for diagnosing SARS-CoV-2 and sampling enables self-collection without causing discomfort or pain. In addition, self-collection of saliva can reduce the exposure to healthcare personnel by avoiding cough, sneezing, and/or aerosolization during sampling.…”
Section: Introductionmentioning
confidence: 99%
“…Some collection sites provide different features. For instance, saliva samples have been reported as a low cost-effective and noninvasive alternative, since it has been used to detect other respiratory viruses [ 31 ]. The collection made by swabs taken from the throat immediately upon symptom onset is 6.4% less effective than nasal swabs to yield positive results in nasal swabs [ 4 ].…”
Section: Influencing Factors On Sars-cov-2 Detectionmentioning
confidence: 99%